Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach
- PMID: 37578562
- DOI: 10.1007/s00284-023-03422-w
Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach
Abstract
Tuberculosis is the disease which is caused due to the contagion of Mycobacterium tuberculosis. The multidrug resistance Mycobacterium tuberculosis is the main hassle in the treatment of this worldwide health threats. Pantothenate synthase is a legitimate goal for rational drug designing against Mycobacterium tuberculosis. The enzyme is most active in the presence of magnesium or manganese. Marine algal cell wall is rich in sulfated polysaccharides such as fucoidans (brown algae), κ-carrageenans (red algae), and ulvan (green algae) with various favorable biological activities such as anticoagulant, antiviral, antioxidative, anticancer, and immunomodulating activities. In this study, we have modeled binding modes of selected known anti-tubercular compounds and different solvent extract against pantothenate synthase using advanced docking program AutoDock 4.2 tool. In our current study, in silico experiments were carried out to determine if fucoidan, κ-carrageenan, and ulvan sulfated polysaccharides could be a potential target against PANc (pantothenate synthetase), with the goal of identifying potential inhibitors as anti-TB leads targeting PANc for further wet lab validation. Two bioactive compounds were docked to the Mtb pantothenate synthetase protein binding site, with docking scores ranging from - 5.57 to - 2.73. κ-carrageenan had the best pose and docking score, with a Ligand fit score of - 5.815. Ulvan did not dock with the protein. The molecular dynamics simulations were conducted with substrate and ligand bounded fucoidan and κ-carrageenan for 150 ns and the protein Mtb pantothenate synthetase showed a stable conformation in the simulation, with tight amino acid contributions binding to the ligand molecule. RMSD characterizes the conformation and stability of protein ligand complexes, with higher fluctuations indicating low stability and minimal low-level fluctuations indicating equilibration and stability. The graph for RMSF shows significant peaks due to fluctuations in active site regions and other peaks indicating the adaptation of the ligand molecule to the protein binding pocket. From the molecular dynamics study, it is clear that the compounds are having good binding affinity in the active site. The root mean square deviation, root mean square fluctuations, and radius of gyration are supportive evidences which helped us to conclude that the compounds κ-carrageenan and fucoidan are suitable lead molecules for inhibiting pantothenate synthetase. Based on these evidences, the natural compounds from seaweeds can be tested clinically either alone or in combinations against the protein, which could facilitate the designing or the synthesis of new lead molecules as drugs against the tuberculosis.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Lead identification against Mycobacterium tuberculosis using highly enriched active molecules against pantothenate synthetase.J Biomol Struct Dyn. 2024;42(20):11080-11097. doi: 10.1080/07391102.2023.2260483. Epub 2023 Sep 25. J Biomol Struct Dyn. 2024. PMID: 37747063
-
Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study.Mol Divers. 2024 Oct;28(5):2783-2799. doi: 10.1007/s11030-023-10711-w. Epub 2023 Aug 14. Mol Divers. 2024. PMID: 37578620
-
Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications.Mar Drugs. 2016 Feb 25;14(3):42. doi: 10.3390/md14030042. Mar Drugs. 2016. PMID: 26927134 Free PMC article. Review.
-
Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.J Biomol Struct Dyn. 2019 Mar;37(4):1043-1053. doi: 10.1080/07391102.2018.1448303. Epub 2018 Mar 13. J Biomol Struct Dyn. 2019. PMID: 29502488
-
Antitumor potential of carrageenans from marine red algae.Carbohydr Polym. 2020 Oct 15;246:116568. doi: 10.1016/j.carbpol.2020.116568. Epub 2020 Jun 12. Carbohydr Polym. 2020. PMID: 32747241 Review.
Cited by
-
Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: A computational approach.Front Pharmacol. 2024 Jul 29;15:1403900. doi: 10.3389/fphar.2024.1403900. eCollection 2024. Front Pharmacol. 2024. PMID: 39135797 Free PMC article.
References
-
- World Health Organization (2023) Tuberculosis. https://www.who.int/news-room/fact-sheets/detail/tuberculosis . Accessed 24 March 2023
-
- Global Tuberculosis Report 2019 (World Health Organization, Geneva (2019) Licence: CC BY-NC-SA
-
- Shah YB, Mistry PS, Dhameliya TM, Ranch KM, Boddu SH, Jacob S, Mahalakshmi B, Renukuntla J (2023) Tuberculosis: current treatment options and future scope. In: Shegokar R, Pathak Y (eds) Tubercular drug delivery systems: advances in treatment of infectious diseases. Springer, Cham, pp 59–77 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous